Unity Biotechnology Inc.

NASDAQ: UBX · Real-Time Price · USD
0.69
0.00 (0.29%)
At close: Jun 06, 2025, 3:37 PM
0.29%
Bid 0.69
Market Cap 11.95M
Revenue (ttm) n/a
Net Income (ttm) -27.5M
EPS (ttm) -1.63
PE Ratio (ttm) -0.43
Forward PE -0.88
Analyst Hold
Ask 0.7
Volume 142,230
Avg. Volume (20D) 172,207
Open 0.69
Previous Close 0.69
Day's Range 0.67 - 0.71
52-Week Range 0.66 - 3.10
Beta 1.06

About UBX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UBX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for UBX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
-4.46%
UBX stock has given up its prior loss. Unity Biote... Unlock content with Pro Subscription
1 month ago
-4.46%
Unity Biotechnology shares are trading lower after the company announced 36-week results from its Phase 2b ASPIRE clinical trial.